Why Male Fertility Problems Are More Common Than Most Men Realize — and What DNA Testing Reveals

About one in seven couples trying to conceive run into trouble, and in roughly half of those cases, the male partner is a contributing factor. That statistic surprises a lot of people. Fertility is still widely framed as a female health issue, and men rarely receive proactive screening until conception has already failed to happen after months or years of trying.

A semen analysis is usually the first test ordered once a couple seeks help. It measures sperm count, motility, and shape — useful information, but far from the whole picture. Many men with perfectly normal semen analysis results still have fertility problems. And many men with abnormal results receive no explanation for why their numbers are off, just a recommendation to try lifestyle changes or assisted reproduction.

What standard fertility workups consistently miss is the genetic layer. Sperm production is an extraordinarily complex biological process — one that depends on gene expression, hormonal signaling, DNA integrity, cellular energy, and structural development all working in coordination. When any of those processes has a genetic variant creating a bottleneck, the result shows up as low count, poor motility, abnormal morphology, or high DNA fragmentation. Knowing which genes are involved doesn’t just explain the problem. It points toward specific, targeted interventions that general advice cannot reach.

How Common Is a Genetic Contribution to Male Infertility?

Estimates vary, but research consistently puts genetic factors as a contributor in 30 to 50 percent of cases that are otherwise labeled “unexplained.” That’s a substantial proportion. The challenge is that routine fertility testing doesn’t look for most of these variants — not because they’re rare or exotic, but because genetic analysis hasn’t historically been part of the standard urology or reproductive endocrinology workup.

Some genetic causes of male infertility are structural and absolute: deletions on the Y chromosome in regions essential for sperm production can result in complete absence of sperm, regardless of what a man does in terms of diet, supplements, or lifestyle. Others are more nuanced — variants that impair efficiency rather than eliminate function, meaning the right interventions can meaningfully improve outcomes.

Understanding which category applies to a given person matters enormously. A man whose infertility stems from impaired methylation and oxidative stress is in a very different situation from one whose reproductive tract never fully developed due to a structural gene variant. Both might have low sperm counts, but the biology is completely different, and so is the path forward.

MTHFR: The Methylation Gene That Affects Sperm DNA Quality

The MTHFR gene encodes an enzyme that converts dietary folate into the active form the body can actually use. This process — methylation — is fundamental to DNA synthesis, repair, and gene regulation throughout the body. In developing sperm cells, it’s particularly important: proper methylation patterns protect sperm DNA from damage during the roughly 74-day maturation cycle.

The C677T variant in the MTHFR gene, carried by an estimated 40 percent of people with European ancestry, reduces enzyme activity by 40 to 70 percent. Men with this variant may have adequate folate in their diet and still be functionally depleted at the cellular level, because the enzyme converting folate into its usable form is working at a fraction of normal speed. The downstream effects can include increased sperm DNA fragmentation, lower sperm counts, reduced motility, and — even when fertilization does occur — elevated miscarriage risk tied to epigenetic damage in the sperm contribution to the embryo.

Standard folic acid supplementation doesn’t fix this. The enzyme required to process folic acid into active methylfolate is the same one that’s compromised. Men with MTHFR variants typically need the pre-converted form — methylfolate — along with methylcobalamin (the active form of B12) to support the methylation cycle effectively.

CFTR: When the Problem Is Structural, Not Hormonal

The CFTR gene is most commonly associated with cystic fibrosis, but only in its most severe forms. A much larger number of people carry CFTR variants that don’t cause lung disease but do affect the reproductive tract. In males, certain CFTR mutations cause the vas deferens — the tube that carries sperm from the testes — to be absent or obstructed, a condition called congenital bilateral absence of the vas deferens (CBAVD).

Men with CBAVD produce sperm normally in the testes, but the sperm have no route out. Hormone levels are typically normal. A semen analysis shows no sperm at all, or an extremely low count. Without genetic testing, the cause is often missed entirely, labeled as unexplained azoospermia.

CFTR carrier status occurs in roughly 1 in 25 people of European ancestry. When both partners carry CFTR variants, there are also implications for the health of any children conceived — which is one reason genetic testing before or during family planning carries real value beyond explaining current fertility problems.

DAZL and Y-Chromosome Deletions: When Sperm Production Fails at the Source

The DAZL gene sits within the azoospermia factor (AZF) region on the Y chromosome and is essential for the earliest stages of sperm cell development. Without functional DAZL, germ cells cannot mature into sperm. There is no workaround and no partial function — either the gene works, or it doesn’t.

DAZL deletions are less common than MTHFR variants, affecting an estimated 1 in 2,000 to 3,000 infertile males. But they tend to cause severe, absolute impairment. Men with AZF deletions typically have either no sperm at all or a count so low that natural conception is not realistic. The diagnosis is frequently delayed by years because standard testing doesn’t screen for it.

Identifying a DAZL or AZF deletion early matters because it clarifies what’s possible. Testicular sperm extraction followed by IVF with intracytoplasmic sperm injection (ICSI) may still allow biological fatherhood in some cases, but the approach requires expert reproductive medicine and ideally genetic counseling before proceeding — particularly given that Y-chromosome deletions are passed to male offspring.

AR: The Androgen Receptor Gene and Testosterone Sensitivity

Here’s a situation that confounds many men and their doctors: testosterone levels come back normal, yet sperm production is poor and fertility is low. One major reason this happens involves the AR gene, which encodes the androgen receptor — the cellular docking site that testosterone must bind to in order to trigger its effects.

Variants in the AR gene can reduce the sensitivity or efficiency of these receptors, meaning cells throughout the body — including the Sertoli cells in the testes that directly support sperm development — aren’t responding adequately to testosterone even when there’s plenty of it circulating. The result is that spermatogenesis is compromised not because testosterone is low, but because the signal isn’t getting through properly at the cellular level.

This distinction is clinically significant. It means that approaches aimed at boosting testosterone levels may not address the underlying problem if the issue is receptor sensitivity rather than hormone quantity. Understanding AR status helps explain why two men with similar testosterone readings can have vastly different fertility outcomes.

COMT and Oxidative Stress: The Slower-Burning Problem

The COMT gene encodes an enzyme that breaks down catecholamines — dopamine, norepinephrine, and epinephrine — as well as estrogens. Variants in COMT that slow this enzyme can lead to higher estrogen levels in men, which suppresses the hypothalamic-pituitary axis and reduces signaling to the testes. The effect on fertility can be significant but subtle, appearing as lower testosterone production or impaired sperm parameters without an obvious hormonal red flag.

COMT variants also influence oxidative stress management, which matters directly for sperm. Sperm cells are particularly vulnerable to oxidative damage because they have very little cytoplasm — and therefore less antioxidant capacity — compared to other cell types. Elevated oxidative stress during the sperm maturation process can cause DNA fragmentation, reduce motility, and impair the sperm’s ability to penetrate an egg.

Detoxification genes including GSTT1 and GSTM1 also bear on this. These genes encode enzymes in the glutathione pathway — the body’s primary antioxidant defense system. Null variants in GSTT1 or GSTM1, where the gene is simply absent rather than merely less active, are found at elevated rates in infertile men compared to fertile controls. Men with these null variants have a reduced capacity to neutralize oxidative damage, and their sperm are more vulnerable to environmental toxins, heat stress, and the oxidative byproducts of normal cellular metabolism.

What Genetic Testing Adds That Standard Workups Can’t

A semen analysis tells you what’s happening. Genetic testing begins to explain why. Those are different questions, and the second one is where treatment decisions actually get made.

Knowing that low sperm count is tied to an MTHFR variant suggests a specific nutritional protocol that standard folate supplementation won’t achieve. Identifying a CFTR structural variant clarifies that no lifestyle optimization will resolve the obstruction and that sperm retrieval with IVF is the practical path. Finding normal DAZL function but impaired AR receptor sensitivity opens a conversation about whether hormone therapy is worth pursuing — and what realistic outcomes look like.

None of this replaces working with a reproductive urologist or fertility specialist. But it gives both the patient and the clinician a more complete picture to work from. For couples who have been through multiple failed cycles or received an “unexplained” label, that added clarity can be both practically useful and deeply relieving.

Understanding the Genetics Behind Male Fertility
The SelfDecode Male Fertility DNA report analyzes key genetic variants affecting sperm production, testosterone response, sperm DNA quality, and reproductive tract development. Genes covered include MTHFR, CFTR, DAZL, AR, COMT, GSTT1, and GSTM1, with personalized, DNA-based recommendations for supplements, diet, and lifestyle. Compatible with existing 23andMe and AncestryDNA raw data — no new DNA kit required to get started.